1. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
   Rokaya El Ansari et al, 2018, British Journal of Cancer CrossRef
2. HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
   Rindert Missiaen et al, 2023, The EMBO Journal CrossRef
3. Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers
   Caroline Papin-Michault et al, 2016, PLOS ONE CrossRef
4. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
   Xinjie Lu, 2019, Current Cancer Drug Targets CrossRef
5. L-Type Amino Acid Transporter 1 (LAT1) Promotes PMA-Induced Cell Migration through mTORC2 Activation at the Lysosome
   Kun Tae et al, 2023, Cells CrossRef
6. CD147-CD98hc Complex Contributes to Poor Prognosis of Non-Small Cell Lung Cancer Patients Through Promoting Cell Proliferation Via the PI3K/Akt Signaling Pathway
   Fei Fei et al, 2014, Annals of Surgical Oncology CrossRef
7. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non–Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B
   William R. Wikoff et al, 2015, Journal of Clinical Oncology CrossRef
8. Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung
   Dong Hoon Shin et al, 2016, Oncotarget CrossRef
9. The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer
   Rokaya El-Ansari et al, 2019, Breast Cancer Research and Treatment CrossRef
10. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells
    Marc Le Vee et al, 2016, Toxicology and Applied Pharmacology CrossRef
11. The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
    Pascal Häfliger et al, 2019, International Journal of Molecular Sciences CrossRef
12. Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
    Marcus Wurlitzer et al, 2020, Cancers CrossRef
13. Diseases & Disorders | Therapies Targeting Glutamine Addiction in Cancer
    Nabeel Attarwala et al, 2021, Encyclopedia of Biological Chemistry III CrossRef
14. ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation
    Catarina Lopes et al, 2021, Cancers CrossRef
15. Prognostic value of LAT-1 status in solid cancer: A systematic review and meta-analysis
    Jing-jing Lu et al, 2020, PLOS ONE CrossRef
16. Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment
    Keitaro Hayashi et al, 2017, World Journal of Gastrointestinal Oncology CrossRef
17. Hypoxia and cellular metabolism in tumour pathophysiology
    Scott K. Parks et al, 2017, The Journal of Physiology CrossRef
18. Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?
    Cecilia Lindskog et al, 2015, Expert Review of Molecular Diagnostics CrossRef
19. Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non‐small cell lung cancer
    Xu Guo et al, 2015, Molecular Carcinogenesis CrossRef
20. Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer
    Masaaki Ichinoe et al, 2021, Journal of Clinical Pathology CrossRef
21. The role of L-type amino acid transporter 1 in human tumors
    Yu Zhao et al, 2015, Intractable & Rare Diseases Research CrossRef
22. Blood-brain barrier transport machineries and targeted therapy of brain diseases
    Jaleh Barar et al, 2016, BioImpacts CrossRef
23. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways
    Xue Zhao et al, 2022, Cancers CrossRef